Fumito Tsuji
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 10%
- Organic Chemistry
- Co-authors
- Kazuhiko NakagawaSeiji NihoAdam PłużańskiMaria Rita MigliorinoYi‐Long WuTao WangKi Hyeong LeeEric Sbar
- Topics
- Lung Cancer Treatments and Mutations (6 papers)Colorectal Cancer Treatments and Studies (4 papers)Gastric Cancer Management and Outcomes (2 papers)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Fumito Tsuji
7 papers receiving 904 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Pulmonary and Respiratory Medicine 822
- Oncology 693
- Molecular Biology 257
- Cancer Research 162
- Organic Chemistry 60
Countries citing papers authored by Fumito Tsuji
This map shows the geographic impact of Fumito Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumito Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumito Tsuji more than expected).
Fields of papers citing papers by Fumito Tsuji
This network shows the impact of papers produced by Fumito Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumito Tsuji. The network helps show where Fumito Tsuji may publish in the future.
Co-authorship network of co-authors of Fumito Tsuji
This figure shows the co-authorship network connecting the top 25 collaborators of Fumito Tsuji. A scholar is included among the top collaborators of Fumito Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumito Tsuji. Fumito Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trialbreakdown → | 854 |
| 3 | 26 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 12 |
About Fumito Tsuji
Fumito Tsuji is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 7 papers that have together received 924 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (693 citations), Pulmonary and Respiratory Medicine (822 citations) and Cancer Research (162 citations). Fumito Tsuji has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Kazuhiko Nakagawa, Seiji Niho, Adam Płużański, Maria Rita Migliorino, Yi‐Long Wu, Tao Wang, Ki Hyeong Lee, Eric Sbar, Xiangdong Zhou and Tony Mok. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.